Medical Device Contract Manufacturing Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Medical Device Contract Manufacturing Market

Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Drug Delivery (Autoinjectors, Infusion Pumps), Diabetes Care, Orthopedic, Ophthalmology, Endoscopy, Surgery) Class of Device (I, II, III) Services - Global Forecasts to 2027

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 7111 Jan, 2023, by marketsandmarkets.com

Updated on : February 28, 2023

The global medical device contract manufacturing market in terms of revenue was estimated to be worth $71.2 billion in 2022 and is poised to reach $118.9 billion by 2027, growing at a CAGR of 10.8% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The market is mainly driven by factors such as the changes in the medical devices industry due to Industry 4.0, the uptake of automation and robotics by manufacturers, and the boost in the medical device market in developing countries. In this report, the global market is segmented into – device type, class of device, service, and region.

Attractive Opportunities in the Medical Device Contract Manufacturing Market

Medical Device Contract Manufacturing Market

To know about the assumptions considered for the study, Request for Free Sample Report

Medical Device Contract Manufacturing Market Dynamics

Driver: Growth in the Medical Devices Market in Developing Countries

In the coming years, China and India are expected to drive growth in the Asia-Pacific region. The GDP growth in India and China is expected to be more than 100% from 2020 to 2040. This can be beneficial for emerging economies. Foreign investments will also rise in this region to capitalize on the abundant opportunities and establish units in the Asia-Pacific region.  Additionally, the increasing number of diagnostic public-private partnerships, and government grants will increase the use of medical devices in the region, leading to a boom in contract manufacturing.

Restraint: Consolidation in the medical devices market by acquiring small and medium-sized companies

To enhance their internal capabilities, the top global medical device manufacturers are acquiring small and medium-sized specialized companies. Other companies are focusing on acquiring CMOs to reduce their expenses related to contract manufacturing. Such developments are expected to transfer a small percentage of manufacturing from CMOs to OEMs.

Opportunity: Increasing healthcare expenditure, infrastructure, and awareness in developing countries

China, India, and other emerging economies offer significant growth opportunities for companies operating in the global market. Compared to other developing countries, these countries have lenient regulatory requirements. Along with that, the increasing healthcare expenditure, the rising prevalence of various chronic and infectious diseases, and the growing demand for home healthcare are some major factors driving the demand for medical devices in developing countries. This has led many manufacturers to set up facilities in these countries.

Challenge: Lack of constant innovation to balance technological capabilities against costs

In a complex market like medical devices, constant innovation is crucial for players to compete. These innovations help contract manufacturers speed up the process, decrease the margin of error, and attract customers. Some of the major capabilities adopted by CMOs in the last few years include process automation, lab automation, robotics, and automated manufacturing. However, all of this comes at a cost. CMOs face significant challenges in handling the requirements of advanced technologies while balancing strong cost pressures.

Among Drug Delivery Devices, the syringes occupied the largest share of the medical device contract manufacturing market.

Based on drug delivery devices, the market is segmented into infusion devices and administration sets, syringes, inhalers, autoinjectors, and pen injectors.

The demand for prefilled syringes has increased due to the zero wastage and zero calibration error of drugs during treatment. This is expected to drive the market for the contract manufacturing of syringes. Additionally, with the growing biologics market and rising chronic disease prevalence, the overall drug delivery devices market is expected to grow significantly.

Based on Service, the packaging and assembly services segment of medical device contract manufacturing market is expected to grow at the highest CAGR in the forecast period.

Under packaging and assembly services, the primary and secondary packaging services sub-segment occupies the largest share and is the fastest-growing segment. This service is highly important for patient safety, adherence to regulations, and barrier protection. The rising importance given to patient safety and regulatory guidelines is expected to translate into a rise in demand for primary and secondary packaging services.

US was the second largest market in the world for medical device contract manufacturing, after China

The US occupied the largest share in North America and the second-largest share globally in the medical device contract manufacturing market. This can mainly be attributed to the increasing price pressure on OEMs, which is encouraging them to take up contract manufacturing as a viable option. Along with this, the demand for medical supplies rose during the COVID-19 pandemic, which in turn led to a rise in the adoption of contract manufacturing services by key medical device OEMs, situated mostly in the US and China.

Medical Device Contract Manufacturing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

A few emerging and key players in the Medical Device Contract Manufacturing market include West Pharmaceutical Services, Inc. (US), Integer Holdings Corporation (US), Celestica Inc. (Canada), Nipro Corporation (Japan), Carclo Plc. (UK), Flex Ltd. (Singapore), Sanmina Corporation (US), and Jabil, Inc. (US).

These companies adopted strategies such as service launches, business expansions, agreements, partnerships, and acquisitions to strengthen their presence in the global market.

Medical Device Contract Manufacturing Market Report Scope

Report Metric

Details

Market Revenue in 2022

$ 71.2 billion

Estimated Value by 2027

$ 118.9 billion

Growth Rate

Poised to grow at a CAGR of 10.8%

Largest Share Segments
  • Cardiovascular devices & Class II medical devices

Market Report Segmentation

Device Type, Class of Device and Region

Growth Drivers
  • Growth in medical devices market in developing countries
  • Adoption of robotics and automation in manufacturing processes
  • Technological advancements in medical device modalities

Growth Opportunities
  • Increasing healthcare expenditure, infrastructure, and awareness in developing countries
  • Rising geriatric population and its associated diseases

Geographies covered

North America, Europe, APAC, MEA, and Latin America

The research report categorizes the medical device contract manufacturing market into the following segments and sub-segments:

Device Type

  • IVD Devices
    • IVD Consumables
    • IVD Equipment
  • Diagnostic Imaging Devices
  • Cardiovascular Devices
  • Drug Delivery Devices
    • Infusion Devices and Administration Sets
    • Syringes
    • Inhalers
    • Autoinjectors and Pen Injectors
  • Orthopedic Devices
  • Respiratory Care Devices
  • Ophthalmology Devices
  • Surgical Devices
  • Diabetes Care Devices
  • Dental Devices
  • Endoscopy and Laparoscopy Devices
  • Gynecology and Urology Devices
  • Personal Care Devices
  • Neurology Devices
  • Patient Monitoring Devices
  • Patient Assistive Devices
  • Other Devices

Class of Device

  • Class I Medical Device
  • Class II Medical Device
  • Class III Medical Device

Service

  • Device Development and Manufacturing Services
    • Device and Component Manufacturing
    • Process Development Services
    • Device Engineering Services
  • Quality Management Services
    • Packaging Validation Services
    • Inspection and Testing Services
    • Sterilization Services
  • Packaging and Assembly Services
    • Primary and Secondary Packaging
    • Labelling
    • Others
  • Other Services

Region

  • Asia Pacific
    • China
    • Japan
    • Malaysia and Singapore
    • India
    • Australia and New Zealand
    • South Korea
    • Rest of Asia Pacific
  • North America
    • US
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East and Africa

Recent Developments

  • In October 2022, Gerresheimer AG (Germany) partnered with Merck, (Germany) for the development of digital solutions for primary packaging systems.
  • In October 2022, Sanmina Corporation (US) entered into a joint venture with Reliance Strategic Business Ventures Limited (RSBVL) (India) to prioritize high-technology infrastructure across various industries, including medical and healthcare systems.
  • In August 2022, TE Connectivity Ltd. (Switzerland) launched Propelus Prototype Center for medical devices at its existing manufacturing site in Galway, Ireland to connect TE engineers with customers to reduce development time and increase speed to market lifesaving and life-improving medical devices.
  • In April 2022, Integer Holdings Corporation (US) acquired Aran Biomedical (Ireland) to increase Integer’s ability to offer complete solutions for complex delivery and therapeutic devices in high-growth cardiovascular markets.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 45)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 MARKET SEGMENTATION
                    FIGURE 2 MARKET: REGIONAL SEGMENTATION
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
          TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 51)
    2.1 RESEARCH DATA 
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 8 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: FLEX, LTD.
          FIGURE 10 SUPPLY SIDE ANALYSIS: MARKET (2021)
          FIGURE 11 DEMAND SIDE ESTIMATION FOR MARKET
          FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
          FIGURE 13 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
           2.2.1 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION 
    2.5 STUDY ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
           2.6.2 SCOPE-RELATED LIMITATIONS
    2.7 RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT: MARKET
    2.8 IMPACT OF RECESSION ON MEDICAL DEVICE CONTRACT MANUFACTURING MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 67)
    FIGURE 15 GLOBAL MARKET, BY DEVICE, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 GLOBAL MARKET, BY CLASS OF DEVICE, 2022 VS. 2027 (USD MILLION)
    FIGURE 17 MARKET, BY SERVICE, 2022 VS. 2027 (USD MILLION)
    FIGURE 18 GEOGRAPHICAL SNAPSHOT OF GLOBAL MARKET
 
4 PREMIUM INSIGHTS (Page No. - 70)
    4.1 MARKET OVERVIEW 
          FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL DEVICE MODALITIES TO DRIVE MARKET
    4.2 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: DEVELOPED VS. DEVELOPING MARKETS 
          FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 GLOBAL MARKET: REGIONAL MIX 
          FIGURE 22 ASIA PACIFIC TO DOMINATE MARKET IN 2027
 
5 MARKET OVERVIEW (Page No. - 72)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 23 MARKET DYNAMICS: MARKET
          TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growth in medical devices market in developing countries
                                FIGURE 24 GDP GROWTH FORECAST: COMPARISON AMONG INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 (FORECAST)
                    5.2.1.2 Adoption of robotics and automation in manufacturing processes
                    5.2.1.3 Technological advancements in medical device modalities
                                FIGURE 25 FACTORS DRIVING DEMAND FOR CONTRACT MANUFACTURING
                    5.2.1.4 Impact of industry 4.0 on medical device industry
                                TABLE 4 DEFINITIONS OF CRITICAL ELEMENTS IN INDUSTRY 4.0 SYSTEM
           5.2.2 RESTRAINTS
                    5.2.2.1 Consolidation in medical devices market by acquiring small and medium-sized companies
                                TABLE 5 KEY ACQUISITIONS IN MEDICAL DEVICE INDUSTRY (2019-2022)
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing healthcare expenditure, infrastructure, and awareness in developing countries
                                TABLE 6 HEALTHCARE EXPENDITURE (%), BY COUNTRY (2010 TO 2021)
                                FIGURE 26 ASIA PACIFIC: HEALTHCARE EXPENDITURE PER CAPITA (USD) (2002 TO 2019)
                    5.2.3.2 Rising geriatric population and its associated diseases
                                TABLE 7 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2019 VS. 2050
                                TABLE 8 AVERAGE LIFE EXPECTANCY, 2023 (FORECAST)
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of constant innovation to balance technological capabilities against costs
    5.3 PORTER’S FIVE FORCES ANALYSIS 
          FIGURE 27 PORTER’S FIVE FORCES ANALYSIS (2020): MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
          TABLE 9 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
                    5.3.1.1 Growth in overall medical device industry
                    5.3.1.2 Demand for compact, cost-effective, and non-invasive devices
                    5.3.1.3 Consolidation
                    5.3.1.4 Poor financing environment
                    5.3.1.5 Stringent regulatory environment
           5.3.2 THREAT OF SUBSTITUTES
                    5.3.2.1 Undesirability of existing portfolios
                    5.3.2.2 Combination and integration of multiple technologies
                    5.3.2.3 Availability of alternatives
           5.3.3 BARGAINING POWER OF SUPPLIERS
                    5.3.3.1 Big medical device contract manufacturing companies
                    5.3.3.2 Institutional technology providers
                    5.3.3.3 Innovative technologies
                    5.3.3.4 Dysfunctional companies
                    5.3.3.5 Academic inventors
           5.3.4 BARGAINING POWER OF BUYERS
                    5.3.4.1 Few buyers and many sellers
                    5.3.4.2 Buy out threat
                    5.3.4.3 Demand for new pipeline services
                    5.3.4.4 Point of differentiation
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
                    5.3.5.1 Similar spectrum of services offered
                    5.3.5.2 Similar funding source
                    5.3.5.3 Self-funded big contract manufacturers
                    5.3.5.4 Highly fragmented industry
    5.4 TARIFF AND REGULATORY LANDSCAPE 
           5.4.1 REGULATORY ANALYSIS
                    5.4.1.1 North America
                               5.4.1.1.1 US
                                             TABLE 10 US: CLASSIFICATION OF MEDICAL EQUIPMENT
                                             TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.4.1.1.2 Canada
                                             TABLE 12 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.4.1.2 Europe
                                TABLE 13 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.4.1.3 Asia Pacific
                               5.4.1.3.1 Japan
                                             TABLE 14 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.4.1.3.2 China
                                             TABLE 15 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.4.1.3.3 India
           5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.5 KEY CONFERENCES AND EVENTS IN 2022–2023 
          TABLE 21 DETAILED LIST OF CONFERENCES AND EVENTS
    5.6 PATENT ANALYSIS 
           5.6.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICES
                    FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2012–NOVEMBER 2022)
           5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
                    FIGURE 29 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL DEVICES PATENTS (JANUARY 2012–NOVEMBER 2022)
                    FIGURE 30 TOP 10 APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICES PATENTS (JANUARY 2012–NOVEMBER 2022)
                    TABLE 22 MEDICAL DEVICES: LIST OF MAJOR PATENTS
    5.7 TECHNOLOGY ANALYSIS 
           5.7.1 KEY TECHNOLOGIES
                    5.7.1.1 Digital Transformation
                    5.7.1.2 Robotics and Automation
           5.7.2 ADJACENT TECHNOLOGIES
                    5.7.2.1 Artificial Intelligence
                    5.7.2.2 Big Data
           5.7.3 COMPLEMENTARY TECHNOLOGIES
                    5.7.3.1 5G
    5.8 SUPPLY CHAIN ANALYSIS 
          FIGURE 31 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2020)
    5.9 ECOSYSTEM ANALYSIS 
          FIGURE 32 MARKET: ECOSYSTEM ANALYSIS (2020)
    5.10 TRADE ANALYSIS 
           TABLE 23 IMPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021
           TABLE 24 EXPORT VALUE OF MEDICAL DEVICES FOR TOP 10 COUNTRIES IN 2021
    5.11 YC-YCC ANALYSIS 
           FIGURE 33 YC-YCC SHIFT IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
    5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
                     TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL DEVICES
           5.12.2 BUYING CRITERIA
                     FIGURE 35 KEY BUYING CRITERIA FOR MEDICAL DEVICES
                     TABLE 26 KEY BUYING CRITERIA FOR MEDICAL DEVICES
    5.13 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING 
           FIGURE 36 ADJACENT MARKETS FOR MEDICAL DEVICE CONTRACT MANUFACTURING
    5.14 INDUSTRY TRENDS 
           5.14.1 INCREASING CONSOLIDATION OF ORIGINAL EQUIPMENT MANUFACTURERS AND CONTRACT MANUFACTURING ORGANIZATIONS
                     TABLE 27 KEY EXAMPLES OF OEM CONSOLIDATION IN LAST 5 YEARS
                     TABLE 28 KEY EXAMPLES OF CMO CONSOLIDATION
           5.14.2 GROWING INTEREST OF PRIVATE EQUITY FIRMS IN MEDICAL DEVICE CONTRACT MANUFACTURING
                     TABLE 29 KEY INVESTMENTS BY PRIVATE EQUITY FIRMS
           5.14.3 OUTSOURCING OF MEDICAL DEVICE CONTRACT MANUFACTURING SERVICES
                     TABLE 30 EXAMPLES OF KEY COLLABORATIONS AND AGREEMENTS
           5.14.4 INDUSTRY 5.0
    5.15 IMPACT OF RECESSION ON MARKET 
 
6 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE (Page No. - 110)
    6.1 INTRODUCTION 
          TABLE 31 MARKET, BY DEVICE, 2020–2027 (USD MILLION)
    6.2 IVD DEVICES 
          TABLE 32 GLOBAL MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 33 MARKET FOR IVD DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.1 IVD CONSUMABLES
                    6.2.1.1 Increasing demand for reagents & kits and focus on COVID-19 screening to drive market
                                TABLE 34 IVD CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 IVD EQUIPMENT
                    6.2.2.1 Advances in life sciences research to support market
                                TABLE 35 IVD EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 DIAGNOSTIC IMAGING DEVICES 
           6.3.1 ADOPTION OF NEW AND ADVANCED DIAGNOSTIC IMAGING SYSTEMS IN DEVELOPING COUNTRIES TO AUGMENT MARKET
                    TABLE 36 GLOBAL MARKET FOR DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 CARDIOVASCULAR DEVICES 
           6.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO PROPEL MARKET
                    TABLE 37 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035
                    TABLE 38 MARKET FOR CARDIOVASCULAR DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 DRUG DELIVERY DEVICES 
          TABLE 39 MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 40 MARKET FOR DRUG DELIVERY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
           6.5.1 INFUSION DEVICES AND ADMINISTRATION SETS
                    6.5.1.1 Rising incidence of chronic diseases and number of surgical procedures to fuel market
                                TABLE 41 INFUSION DEVICES AND ADMINISTRATION SETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.5.2 SYRINGES
                    6.5.2.1 High cost of safety syringes and increasing incidence of needlestick injuries to hinder market
                                TABLE 42 SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.5.3 INHALERS
                    6.5.3.1 High prevalence of asthma, COPD, and cystic fibrosis to aid market
                                TABLE 43 INHALERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.5.4 AUTOINJECTORS AND PEN INJECTORS
                    6.5.4.1 Rising number of regulatory approvals for new drug therapies and advancements to support market
                                TABLE 44 RECENT APPROVALS FOR AUTOINJECTORS AND PEN INJECTORS GLOBALLY (2019-2022)
                                TABLE 45 AUTOINJECTORS AND PEN INJECTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.6 ORTHOPEDIC DEVICES 
           6.6.1 HIGH PREVALENCE OF ORTHOPEDIC CONDITIONS TO DRIVE MARKET
                    TABLE 46 MARKET FOR ORTHOPEDIC DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.7 RESPIRATORY CARE DEVICES 
           6.7.1 COVID-19 TO BOOST DEMAND FOR CONTRACT MANUFACTURING OF RESPIRATORY CARE DEVICES
                    TABLE 47 MARKET FOR RESPIRATORY CARE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.8 OPHTHALMOLOGY DEVICES 
           6.8.1 INCREASING PREVALENCE OF OPHTHALMIC DISEASES TO DRIVE MARKET
                    TABLE 48 MARKET FOR OPHTHALMOLOGY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.9 SURGICAL DEVICES 
           6.9.1 INCREASE IN SURGICAL PROCEDURES TO FUEL MARKET
                    TABLE 49 MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.10 DIABETES CARE DEVICES 
           6.10.1 RISING PREVALENCE OF DIABETES TO PROPEL MARKET
                     TABLE 50 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20-79 YEARS) (2021 VS. 2045)
                     TABLE 51 MARKET FOR DIABETES CARE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.11 DENTAL DEVICES 
           6.11.1 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET
                     TABLE 52 MARKET FOR DENTAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.12 ENDOSCOPY AND LAPAROSCOPY DEVICES 
           6.12.1 RISING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET
                     TABLE 53 MARKET FOR ENDOSCOPY AND LAPAROSCOPY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.13 GYNECOLOGY AND UROLOGY DEVICES 
           6.13.1 GROWING AWARENESS AND PREVENTIVE CHECK-UPS FOR LATE-PHASE DIAGNOSIS OF STDS TO PROPEL MARKET
                     FIGURE 37 US: NUMBER OF CASES OF SEXUALLY TRANSMITTED DISEASES, 2017 VS. 2021
                     TABLE 54 MARKET FOR GYNECOLOGY AND UROLOGY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.14 PERSONAL CARE DEVICES 
           6.14.1 SHIFT IN CONSUMPTION PATTERN TOWARD PREMIUM PERSONAL CARE PRODUCTS TO FUEL MARKET
                     TABLE 55 MARKET FOR PERSONAL CARE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.15 NEUROLOGY DEVICES 
           6.15.1 RISING GLOBAL BURDEN OF NEUROLOGICAL DISEASES TO DRIVE MARKET
                     TABLE 56 MARKET FOR NEUROLOGY DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.16 PATIENT MONITORING DEVICES 
           6.16.1 GROWING AVAILABILITY OF INTEGRATED MONITORING TECHNOLOGY TO AID MARKET
                     TABLE 57 MARKET FOR PATIENT MONITORING DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.17 PATIENT ASSISTIVE DEVICES 
           6.17.1 RISING GERIATRIC POPULATION GLOBALLY TO PROPEL MARKET
                     TABLE 58 MARKET FOR PATIENT ASSISTIVE DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.18 OTHER DEVICES 
           TABLE 59 MARKET FOR OTHER DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
 
7 MARKET, BY CLASS OF DEVICE (Page No. - )
    7.1 INTRODUCTION 
          TABLE 60 MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
    7.2 COMPARISON OF DEVICE CLASSIFICATION BY COUNTRY/REGION 
           7.2.1 US
                    7.2.1.1 Class I: General controls
                    7.2.1.2 Class II: General controls with special controls
                    7.2.1.3 Class III: General controls with special controls and premarket approval
           7.2.2 CANADA
           7.2.3 EUROPEAN UNION AND EUROPEAN FREE TRADE ASSOCIATION
                    7.2.3.1 Class I medical devices
                               7.2.3.1.1 Class Is: Non-invasive devices
                               7.2.3.1.2 Class Ir: Reusable surgical instruments
                               7.2.3.1.3 Class Im: Low-risk measuring devices
                    7.2.3.2 Class IIa medical devices
                    7.2.3.3 Class IIb medical devices
                    7.2.3.4 Class III medical devices
           7.2.4 ASIA PACIFIC
                    7.2.4.1 China
                    7.2.4.2 India
                    7.2.4.3 Japan
                    7.2.4.4 Australia
    7.3 CLASS II MEDICAL DEVICES 
           7.3.1 HIGH-VOLUME UTILIZATION OF CLASS II MEDICAL DEVICES BY END USERS TO SUPPORT MARKET
                    TABLE 61 MARKET FOR CLASS II MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 CLASS I MEDICAL DEVICES 
           7.4.1 CLASS I MEDICAL DEVICES TO POSSESS MINIMUM POTENTIAL TO HARM USERS
                    TABLE 62 MARKET FOR CLASS I MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 CLASS III MEDICAL DEVICES 
           7.5.1 CLASS III MEDICAL DEVICES TO INVOLVE HIGHEST LEVEL OF HEALTH RISKS
                    TABLE 63 MARKET FOR CLASS III MEDICAL DEVICES, BY COUNTRY, 2020–2027 (USD MILLION)
 
8 MARKET, BY SERVICE (Page No. - 160)
    8.1 INTRODUCTION 
          FIGURE 38 STAGES INVOLVED IN CONTRACT MANUFACTURING OF MEDICAL DEVICES
          TABLE 64 MARKET, BY SERVICE, 2020–2027 (USD MILLION)
    8.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES 
          TABLE 65 MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 66 MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.1 DEVICE AND COMPONENT MANUFACTURING SERVICES
                    8.2.1.1 Device manufacturing services to be largest and fastest-growing segment
                                TABLE 67 DEVICE AND COMPONENT MANUFACTURING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.2 PROCESS DEVELOPMENT SERVICES
                    8.2.2.1 Transition from conventional contract manufacturing to automated contract manufacturing and testing to drive growth
                                FIGURE 39 DEVICE PROCESS DEVELOPMENT SERVICES
                                TABLE 68 PROCESS DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.3 DEVICE ENGINEERING SERVICES
                    8.2.3.1 Complexity of device engineering services to propel segment
                                TABLE 69 DEVICE ENGINEERING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 QUALITY MANAGEMENT SERVICES 
          TABLE 70 MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 71 MARKET FOR QUALITY MANAGEMENT SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.1 PACKAGING VALIDATION SERVICES
                    8.3.1.1 Increasing product safety concerns for medical devices to aid market
                                TABLE 72 PACKAGING VALIDATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.2 INSPECTION AND TESTING SERVICES
                    8.3.2.1 Increased technological expertise in testing services to eliminate large capital and overhead investments
                                TABLE 73 INSPECTION AND TESTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.3 STERILIZATION SERVICES
                    8.3.3.1 Rising complexity of sterility standards to augment market
                                TABLE 74 MEDICAL DEVICE STERILIZATION PATENTS PUBLISHED BY MAJOR COMPANIES WORLDWIDE
                                TABLE 75 STERILIZATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    8.4 PACKAGING AND ASSEMBLY SERVICES 
          FIGURE 40 FINAL ASSEMBLY SERVICES IN GLOBAL VALUE CHAIN OF MEDICAL DEVICES
          TABLE 76 MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 77 MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
           8.4.1 PRIMARY AND SECONDARY PACKAGING SERVICES
                    8.4.1.1 Growing concerns for patient safety to aid segment
                                TABLE 78 PRIMARY AND SECONDARY PACKAGING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           8.4.2 LABELING SERVICES
                    8.4.2.1 Export bans and product recalls due to improper labeling to support market
                                TABLE 79 LABELING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           8.4.3 OTHER PACKAGING AND ASSEMBLY SERVICES
                    TABLE 80 OTHER PACKAGING AND ASSEMBLY SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    8.5 OTHER SERVICES 
          TABLE 81 MARKET FOR OTHER SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
 
9 MARKET, BY REGION (Page No. - 180)
    9.1 INTRODUCTION 
          FIGURE 41 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          TABLE 82 MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.2 ASIA PACIFIC 
           9.2.1 IMPACT OF RECESSION
                    FIGURE 42 ASIA PACIFIC: MARKET SNAPSHOT
                    TABLE 83 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 84 ASIA PACIFIC: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                    TABLE 85 ASIA PACIFIC: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 86 ASIA PACIFIC: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 87 ASIA PACIFIC: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                    TABLE 88 ASIA PACIFIC: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 89 ASIA PACIFIC: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 90 ASIA PACIFIC: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 91 ASIA PACIFIC: MARKET PACKAGING & ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.2.2 CHINA
                    9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market
                                TABLE 92 CHINA: KEY MACROINDICATORS
                                TABLE 93 CHINA: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 94 CHINA: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 95 CHINA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 96 CHINA: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 97 CHINA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 98 CHINA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 99 CHINA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 100 CHINA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.2.3 JAPAN
                    9.2.3.1 Universal healthcare reimbursement policies to propel market
                                TABLE 101 JAPAN: KEY MACROINDICATORS
                                TABLE 102 JAPAN: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 103 JAPAN: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 104 JAPAN: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 105 JAPAN: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 106 JAPAN: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 107 JAPAN: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 108 JAPAN: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 109 JAPAN: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.2.4 MALAYSIA AND SINGAPORE
                    9.2.4.1 Increasing R&D activities and investments by established players to augment market
                                TABLE 110 MALAYSIA: KEY MACROINDICATORS
                                TABLE 111 SINGAPORE: KEY MACROINDICATORS
                                TABLE 112 MALAYSIA AND SINGAPORE: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 113 MALAYSIA AND SINGAPORE: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 114 MALAYSIA AND SINGAPORE: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 115 MALAYSIA AND SINGAPORE: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 116 MALAYSIA AND SINGAPORE: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 117 MALAYSIA AND SINGAPORE: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 118 MALAYSIA AND SINGAPORE: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 119 MALAYSIA AND SINGAPORE: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.2.5 INDIA
                    9.2.5.1 Rising contract manufacturing capabilities to support market
                                TABLE 120 INDIA: KEY MACROINDICATORS
                                TABLE 121 INDIA: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 122 INDIA: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 123 INDIA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 124 INDIA: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 125 INDIA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 126 INDIA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 127 INDIA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 128 INDIA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.2.6 AUSTRALIA AND NEW ZEALAND
                    9.2.6.1 Need for advanced medical and diagnostic tools to fuel market
                                TABLE 129 AUSTRALIA: KEY MACROINDICATORS
                                TABLE 130 NEW ZEALAND: KEY MACROINDICATORS
                                TABLE 131 AUSTRALIA AND NEW ZEALAND: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 132 AUSTRALIA AND NEW ZEALAND: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 133 AUSTRALIA AND NEW ZEALAND: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 134 AUSTRALIA AND NEW ZEALAND: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 135 AUSTRALIA AND NEW ZEALAND: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 136 AUSTRALIA AND NEW ZEALAND: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 137 AUSTRALIA AND NEW ZEALAND: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 138 AUSTRALIA AND NEW ZEALAND: MARKET FOR PACKAGING AND ASSEMBLY SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
           9.2.7 SOUTH KOREA
                    9.2.7.1 High-value imports from other countries to offer opportunities
                                TABLE 139 SOUTH KOREA: MEDICAL DEVICES MARKET (USD BILLION)
                                TABLE 140 SOUTH KOREA: KEY MACROINDICATORS
                                TABLE 141 SOUTH KOREA: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 142 SOUTH KOREA: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 143 SOUTH KOREA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 144 SOUTH KOREA: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 145 SOUTH KOREA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 146 SOUTH KOREA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 147 SOUTH KOREA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 148 SOUTH KOREA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.2.8 REST OF ASIA PACIFIC
                    TABLE 149 REST OF ASIA PACIFIC: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                    TABLE 150 REST OF ASIA PACIFIC: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 151 REST OF ASIA PACIFIC: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 152 REST OF ASIA PACIFIC: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                    TABLE 153 REST OF ASIA PACIFIC: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 154 REST OF ASIA PACIFIC: DEVICE DEVELOPMENT & MANUFACTURING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 155 REST OF ASIA PACIFIC: QUALITY MANAGEMENT SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 156 REST OF ASIA PACIFIC: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
    9.3 NORTH AMERICA 
           9.3.1 IMPACT OF RECESSION
                    TABLE 157 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 158 NORTH AMERICA: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                    TABLE 159 NORTH AMERICA: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 160 NORTH AMERICA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 161 NORTH AMERICA: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                    TABLE 162 NORTH AMERICA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 163 NORTH AMERICA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 164 NORTH AMERICA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 165 NORTH AMERICA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.3.2 US
                    9.3.2.1 Increasing in-house manufacturing costs to encourage medical device companies toward contract manufacturing
                                TABLE 166 US: KEY MACROINDICATORS
                                TABLE 167 US: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 168 US: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 169 US: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 170 US: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 171 US: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 172 US: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 173 US: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 174 US: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.3.3 CANADA
                    9.3.3.1 Strong presence of key contract manufacturing companies to augment market
                                TABLE 175 CANADA: KEY MACROINDICATORS
                                TABLE 176 CANADA: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 177 CANADA: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 178 CANADA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 179 CANADA: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 180 CANADA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 181 CANADA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 182 CANADA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 183 CANADA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
    9.4 EUROPE 
           9.4.1 IMPACT OF RECESSION
                    TABLE 184 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 185 EUROPE: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                    TABLE 186 EUROPE: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 187 EUROPE: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 188 EUROPE: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                    TABLE 189 EUROPE: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 190 EUROPE: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 191 EUROPE: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 192 EUROPE: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.4.2 GERMANY
                    9.4.2.1 Germany to hold largest market share due to presence of major device manufacturers and high healthcare expenditure
                                TABLE 193 GERMANY: KEY MACROINDICATORS
                                TABLE 194 GERMANY: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 195 GERMANY: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 196 GERMANY: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 197 GERMANY: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 198 GERMANY: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 199 GERMANY: MARKET FOR DEVICE DEVELOPMENT & MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 200 GERMANY: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 201 GERMANY: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.4.3 FRANCE
                    9.4.3.1 Increasing government pressure for healthcare cost reduction and budgetary constraints to support market
                                TABLE 202 FRANCE: KEY MACROINDICATORS
                                TABLE 203 FRANCE: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 204 FRANCE: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 205 FRANCE: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 206 FRANCE: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 207 FRANCE: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 208 FRANCE: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 209 FRANCE: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 210 FRANCE: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.4.4 UK
                    9.4.4.1 Rising number of accredited clinical and hospital laboratories to propel market
                                TABLE 211 UK: KEY MACROINDICATORS
                                TABLE 212 UK: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 213 UK: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 214 UK: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 215 UK: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 216 UK: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 217 UK: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 218 UK: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 219 UK: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.4.5 ITALY
                    9.4.5.1 Healthcare coverage for all citizens and foreign residents to increase demand for medical devices
                                TABLE 220 ITALY: KEY MACROINDICATORS
                                TABLE 221 ITALY: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 222 ITALY: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 223 ITALY: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 224 ITALY: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 225 ITALY: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 226 ITALY: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 227 ITALY: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 228 ITALY: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.4.6 SPAIN
                    9.4.6.1 Increasing adoption of home-based medical devices to drive market
                                TABLE 229 SPAIN: KEY MACROINDICATORS
                                TABLE 230 SPAIN: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 231 SPAIN: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 232 SPAIN: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 233 SPAIN: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 234 SPAIN: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 235 SPAIN: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 236 SPAIN: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 237 SPAIN: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
           9.4.7 REST OF EUROPE
                    TABLE 238 REST OF EUROPE: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                    TABLE 239 REST OF EUROPE: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 240 REST OF EUROPE: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 241 REST OF EUROPE: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                    TABLE 242 REST OF EUROPE: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 243 REST OF EUROPE: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 244 REST OF EUROPE: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 245 REST OF EUROPE: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 IMPACT OF RECESSION
                    TABLE 246 LATIN AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 247 LATIN AMERICA: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                    TABLE 248 LATIN AMERICA: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 249 LATIN AMERICA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 250 LATIN AMERICA: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                    TABLE 251 LATIN AMERICA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 252 LATIN AMERICA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 253 LATIN AMERICA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 254 LATIN AMERICA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Mexico to be largest segment of Latin American medical device contract manufacturing market
                                TABLE 255 MEXICO: KEY MACROINDICATORS
                                TABLE 256 MEXICO: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 257 MEXICO: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 258 MEXICO: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 259 MEXICO: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 260 MEXICO: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 261 MEXICO: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 262 MEXICO: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 263 MEXICO: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.5.3 BRAZIL
                    9.5.3.1 Favorable government initiatives and willingness to pay for better healthcare to boost market
                                TABLE 264 BRAZIL: KEY MACROINDICATORS
                                TABLE 265 BRAZIL: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                                TABLE 266 BRAZIL: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 267 BRAZIL: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 268 BRAZIL: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                                TABLE 269 BRAZIL: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                                TABLE 270 BRAZIL: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 271 BRAZIL: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 272 BRAZIL: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
           9.5.4 REST OF LATIN AMERICA
                    TABLE 273 REST OF LATIN AMERICA: MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                    TABLE 274 REST OF LATIN AMERICA: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 275 REST OF LATIN AMERICA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 276 REST OF LATIN AMERICA: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                    TABLE 277 REST OF LATIN AMERICA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 278 REST OF LATIN AMERICA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 279 REST OF LATIN AMERICA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 280 REST OF LATIN AMERICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 IMPACT OF RECESSION
           9.6.2 GROWING HEALTHCARE INVESTMENTS AND IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
                    TABLE 281 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONTRACT MANUFACTURING MARKET, BY DEVICE, 2020–2027 (USD MILLION)
                    TABLE 282 MIDDLE EAST & AFRICA: MARKET FOR IVD DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 283 MIDDLE EAST & AFRICA: MARKET FOR DRUG DELIVERY DEVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 284 MIDDLE EAST & AFRICA: MARKET, BY CLASS OF DEVICE, 2020–2027 (USD MILLION)
                    TABLE 285 MIDDLE EAST & AFRICA: MARKET, BY SERVICE, 2020–2027 (USD MILLION)
                    TABLE 286 MIDDLE EAST & AFRICA: MARKET FOR DEVICE DEVELOPMENT AND MANUFACTURING SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 287 MIDDLE EAST & AFRICA: MARKET FOR QUALITY MANAGEMENT SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 288 MIDDLE EAST & AFRICA: MARKET FOR PACKAGING AND ASSEMBLY SERVICES, BY TYPE, 2020–2027 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 296)
     10.1 OVERVIEW 
     10.2 KEY STRATEGIES ADOPTED BY PLAYERS 
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 43 TOP MARKET PLAYERS DOMINATE MEDICAL DEVICE CONTRACT MANUFACTURING MARKET
     10.4 GLOBAL MARKET SHARE (2021) 
             TABLE 289 GLOBAL MARKET: DEGREE OF COMPETITION
     10.5 MARKET SHARE ANALYSIS 
             FIGURE 44 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
     10.6 COMPANY EVALUATION QUADRANT 
             10.6.1 STARS
             10.6.2 EMERGING LEADERS
             10.6.3 PERVASIVE PLAYERS
             10.6.4 PARTICIPANTS
                        FIGURE 45 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION QUADRANT (2021)
     10.7 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021) 
             10.7.1 PROGRESSIVE COMPANIES
             10.7.2 DYNAMIC COMPANIES
             10.7.3 STARTING BLOCKS
             10.7.4 RESPONSIVE COMPANIES
                        FIGURE 46 MEDICAL DEVICE CONTRACT MANUFACTURING MARKET: SMES/START-UPS COMPANY EVALUATION QUADRANTS, 2021
     10.8 COMPETITIVE BENCHMARKING 
             10.8.1 COMPANY FOOTPRINT FOR KEY PLAYERS
             10.8.2 DEVICE: COMPANY FOOTPRINT (1/2)
             10.8.3 DEVICE: COMPANY FOOTPRINT (2/2)
             10.8.4 CLASS OF DEVICE: COMPANY FOOTPRINT
             10.8.5 SERVICE: COMPANY FOOTPRINT
     10.9 REGION: COMPANY FOOTPRINT 
     10.10 GLOBAL MARKET: R&D EXPENDITURE 
             FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN MEDICAL DEVICE CONTRACT MANUFACTURING MARKET (2020/2021)
     10.11 COMPETITIVE SCENARIO 
             10.11.1 PRODUCT LAUNCHES
                        TABLE 290 PRODUCT LAUNCHES (JANUARY 2019– NOVEMBER 2022)
             10.11.2 DEALS
                        TABLE 291 DEALS (JANUARY 2019–NOVEMBER 2022)
             10.11.3 OTHER DEVELOPMENTS
                        TABLE 292 OTHER DEVELOPMENTS (JANUARY 2019–NOVEMBER 2022)
 
11 COMPANY PROFILES (Page No. - 315)
     11.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             11.1.1 JABIL INC.
                        TABLE 293 JABIL INC.: COMPANY OVERVIEW
                        FIGURE 48 JABIL INC.: COMPANY SNAPSHOT (2022)
             11.1.2 FLEX LTD.
                        TABLE 294 FLEX LTD.: COMPANY OVERVIEW
                        FIGURE 49 FLEX LTD.: COMPANY SNAPSHOT (2022)
             11.1.3 PLEXUS CORP.
                        TABLE 295 PLEXUS CORP.: COMPANY OVERVIEW
                        FIGURE 50 PLEXUS CORP.: COMPANY SNAPSHOT (2021)
             11.1.4 SANMINA CORPORATION
                        TABLE 296 SANMINA CORPORATION: COMPANY OVERVIEW
                        FIGURE 51 SANMINA CORPORATION: COMPANY SNAPSHOT (2021)
             11.1.5 INTEGER HOLDINGS CORPORATION
                        TABLE 297 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
                        FIGURE 52 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
             11.1.6 TE CONNECTIVITY LTD.
                        TABLE 298 TE CONNECTIVITY LTD.: COMPANY OVERVIEW
                        FIGURE 53 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2021)
             11.1.7 NIPRO CORPORATION
                        TABLE 299 NIPRO CORPORATION: COMPANY OVERVIEW
                        FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.8 CELESTICA INC.
                        TABLE 300 CELESTICA INC.: COMPANY OVERVIEW
                        FIGURE 55 CELESTICA INC.: COMPANY SNAPSHOT (2021)
             11.1.9 WEST PHARMACEUTICAL SERVICES, INC.
                        TABLE 301 WEST PHARMACEUTICALS SERVICES, INC.: COMPANY OVERVIEW
                        FIGURE 56 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2021)
             11.1.10 BENCHMARK ELECTRONICS INC.
                        TABLE 302 BENCHMARK ELECTRONICS INC.: COMPANY OVERVIEW
                        FIGURE 57 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2021)
             11.1.11 RECIPHARM AB
                        TABLE 303 RECIPHARM AB: COMPANY OVERVIEW
             11.1.12 GERRESHEIMER AG
                        TABLE 304 GERRESHEIMER AG.: COMPANY OVERVIEW
                        FIGURE 58 GERRESHEIMER AG: COMPANY SNAPSHOT (2021)
             11.1.13 KIMBALL ELECTRONICS, INC.
                        TABLE 305 KIMBALL ELECTRONICS, INC.: COMPANY OVERVIEW
                        FIGURE 59 KIMBALL ELECTRONICS, INC.: COMPANY SNAPSHOT (2022)
     11.2 OTHER PLAYERS 
             11.2.1 NORTECH SYSTEMS INCORPORATED
                        TABLE 306 NORTECH SYSTEMS INCORPORATED: COMPANY OVERVIEW
                        FIGURE 60 NORTECH SYSTEM INCORPORATED: COMPANY SNAPSHOT (2021)
             11.2.2 NEMERA
                        TABLE 307 NEMERA: COMPANY OVERVIEW
             11.2.3 VIANT MEDICAL HOLDINGS, INC.
                        TABLE 308 VIANT MEDICAL HOLDINGS, INC.: COMPANY OVERVIEW
             11.2.4 TECOMET, INC.
                        TABLE 309 TECOMET INC.: COMPANY OVERVIEW
             11.2.5 SMC LTD.
                        TABLE 310 SMC LTD.: COMPANY OVERVIEW
             11.2.6 PHILLIPS-MEDISIZE CORPORATION
                        TABLE 311 PHILLIPS-MEDISIZE CORPORATION: COMPANY OVERVIEW
             11.2.7 TESSY PLASTICS CORP.
                        TABLE 312 TESSY PLASTICS CORP.: COMPANY OVERVIEW
             11.2.8 CARCLO PLC
                        TABLE 313 CARCLO PLC: COMPANY OVERVIEW
                        FIGURE 61 CARCLO PLC: COMPANY SNAPSHOT (2021)
             11.2.9 NOLATO GW, INC. (A PART OF NOLATO AB)
                        TABLE 314 NOLATO GW, INC.: COMPANY OVERVIEW
                        FIGURE 62 NOLATO GW, INC.: COMPANY SNAPSHOT (2021)
             11.2.10 MEHOW
                        TABLE 315 MEHOW: COMPANY OVERVIEW
             11.2.11 TEKNI-PLEX
                        TABLE 316 TEKNI-PLEX: COMPANY OVERVIEW
             11.2.12 PETER’S TECHNOLOGY
                        TABLE 317 PETER’S TECHNOLOGY: COMPANY OVERVIEW
 
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 405)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify segmentation types, key players, the competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the leukapheresis market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the leukapheresis market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents for the medical device contract manufacturing market is provided below:

Medical Device Contract Manufacturing Market Size, and Share

Tiers are defined based on a company’s total revenue. As of 2021: Tier 1= >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3= <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the medical device contract manufacturing market was arrived at after data triangulation as mentioned below.

Approach to calculating the revenue of different players in the medical device contract manufacturing market

The size of the global medical device contract manufacturing market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global medical device contract manufacturing market was derived.

Approach to derive the market size and estimate market growth

The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Objectives of the Study

  • To define, describe, and forecast the medical device contract manufacturing market by device type, class of device, service, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the medical device contract manufacturing market with respect to five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key players in the medical device contract manufacturing market as well as comprehensively analyze their core competencies
  • To track and analyze competitive developments such as product launches; acquisitions; expansions; as well as collaborations, agreements, and partnerships of the leading players in the medical device contract manufacturing market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific medical device contract manufacturing market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
  • Further breakdown of the Rest of Europe medical device contract manufacturing market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
  • Further breakdown of the Rest of Latin America medical device contract manufacturing market into Argentina, Peru, and other countries.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 7111
Published ON
Jan, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Medical Device Contract Manufacturing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback